Berlin Institute of Health Cell Sequencing COVID-19 Solutions Intel Chip Chat episode 704

Published: June 23, 2020, 12:10 a.m.

On this episode of Chip Chat, Dr. Roland Eils, the founding director of the BIH Digital Health Center of the Berlin Institute of Health (BIH), talks with host Allyson Klein about their advanced COVID-19 cell sequencing research and how critical technology is in delivering timely results within the medical industry. \n\nDuring their talk, Dr. Eils explains BIH\u2019s process in collecting COVID-19 samples from infected patients and establishing a pipeline through molecular categorization by massive genome sequencing. This large amount of data is used to help predict infected patients\u2019 progression and recommend medical solutions. Intel\u2019s Select Solution architecture tailored to BIH\u2019s workload requirements has accelerated patient research and enabled quicker medical diagnostics. The two also discuss the instrumental role of the IT industry in integrating and processing large amounts of critical medical data. Finally, Dr. Eils describe the institute\u2019s future plans to research the after-recovery effects of COVID-19 patients with international clinical data. \n\nTo learn more about the Berlin Institute of Health and their project on COVID-19 cell sequencing, visit https://www.bihealth.org/en/.\n\nNotices & Disclaimers\nIntel technologies may require enabled hardware, software or service activation.\nNo product or component can be absolutely secure. \nYour costs and results may vary. \n\xa9 Intel Corporation. Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands may be claimed as the property of others.